DAK HEALTH has floated a tender for Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Substance Rituximab, Atc L01af01 for the Period August 1St, 2023 - July 31St, 2025. The project location is Germany and the tender is closing on 05 Jun 2025. The tender notice number is -, while the TOT Ref Number is 84332916.
Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : Germany
Summary : Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Substance Rituximab, Atc L01af01 for the Period August 1St, 2023 - July 31St, 2025
Sign in with Google